EVLO

Evelo Biosciences (EVLO)

About Evelo Biosciences (EVLO)

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$3.59
52 Week Low
$0.00
Market cap
1,900
Dividend yield
0.00%
Volume
11
Avg. volume
840
P/E ratio
.00

Evelo Biosciences News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$3.59
52 Week Low
$0.00
Market cap
1,900
Dividend yield
0.00%
Volume
11
Avg. volume
840
P/E ratio
.00